343 results on '"Moriarty, James P."'
Search Results
2. Cost-effectiveness of Myomectomy versus Hysterectomy in Women with Uterine Fibroids
3. Cost-Effectiveness of an Adjuvanted Hepatitis B Vaccine (HEPLISAV-B) in Patients With Inflammatory Bowel Disease.
4. Yttrium-90 Ibritumomab Tiuxetan is Cost-Effective Compared to Bendamustine + Rituximab in Low-grade Lymphomas
5. Coronary Reactivity Assessment Is Associated With Lower Health Care–Associated Costs in Patients Presenting With Angina and Nonobstructive Coronary Artery Disease
6. FIRSTT study: randomized controlled trial of uterine artery embolization vs focused ultrasound surgery.
7. Cost-effectiveness of the anti-fibrotics for the treatment of idiopathic pulmonary fibrosis in the United States
8. Initial and subsequent 3-year cost after hospitalization for first acute ischemic stroke and intracerebral hemorrhage
9. Impact of patient factors and procedure on readmission after aortic dissection admission in the states of Florida and New York
10. A model-based cost-effectiveness analysis of pharmacogenomic panel testing in cardiovascular disease management: preemptive, reactive, or none?
11. Comparing Outcomes and Cost Between Pancreas Transplant and Standard of Care in Patients With Type 1 Diabetes
12. Comparative Cost-effectiveness of Contemporary Treatment Strategies for Stage IIA Seminoma
13. Author's Reply
14. Comparative cost-effectiveness of contemporary treatment strategies for stage IIA seminoma.
15. A cost-effectiveness analysis assessing systemic treatments in metastatic castration-sensitive prostate cancer (mCSPC) by volume of disease.
16. Patient- and Provider-Level Factors Associated With Telehealth Utilization Across a Multisite, Multiregional Cancer Practice From 2019 to 2021
17. Implementation of prospective, surgeon-driven, risk-based pathway for pancreatoduodenectomy results in improved clinical outcomes and first year cost savings of $1 million
18. Costs associated with Barrett’s esophagus screening in the community: an economic analysis of a prospective randomized controlled trial of sedated versus hospital unsedated versus mobile community unsedated endoscopy
19. Comparative costs for critically ill patients with limited English proficiency versus English proficiency
20. MP33-03 COMPARATIVE COST-EFFECTIVENESS OF TREATMENT STRATEGIES FOR STAGE IIA SEMINOMA: INSIGHTS FROM THE SEMS TRIAL
21. Association between smoking cessation and post-hospitalization healthcare costs: a matched cohort analysis
22. Routine Continuous Electrocardiographic Monitoring Following Percutaneous Coronary Interventions
23. Evaluating the cost-effectiveness of testing pregnant women for penicillin allergy
24. Yttrium-90 Ibritumomab Tiuxetan is Cost-effective compared to Bendamustine + Rituximab in low-grade Lymphomas
25. Reply to Idelevich and Beck
26. Randomized Trial of Rapid Multiplex Polymerase Chain Reaction–Based Blood Culture Identification and Susceptibility Testing
27. Cost evaluation of the Merlin assay for predicting melanoma sentinel lymph node biopsy metastasis
28. Cost-of-care analysis between patients with cancer with COVID-19 utilizing a remote patient-monitoring program versus usual care.
29. Modeling the Cost of Teleneonatology from the Health System Perspective
30. Optimizing Blood Transfusion Practices Through Bundled Intervention Implementation in Patients With Gynecologic Cancer Undergoing Laparotomy
31. Cost‐Effectiveness of a Care Transitions Program in a Multimorbid Older Adult Cohort
32. Evaluating implementation of a rapid response team: considering alternative outcome measures
33. Patient- and provider-level factors associated with telehealth utilization across a multisite, multiregional cancer practice.
34. MP39-13 COST-EFFECTIVENESS OF NEOADJUVANT CHEMOTHERAPY REGIMENS PRIOR TO RADICAL CYSTECTOMY FOR MUSCLE-INVASIVE BLADDER CANCER
35. Parent Motivation Strategies and the Performance of Preschoolers in a Rural Philippine Municipality
36. Abdominal Incision Injection of Liposomal Bupivacaine and Opioid Use After Laparotomy for Gynecologic Malignancies
37. Cost-effectiveness of Adjuvant Pembrolizumab After Nephrectomy for High-risk Renal Cell Carcinoma: Insights for Patient Selection From a Markov Model.
38. Cost evaluation of the Merlin assay for predicting melanoma sentinel lymph node biopsy metastasis.
39. The Effects of Incremental Costs of Smoking and Obesity on Health Care Costs Among Adults: A 7-Year Longitudinal Study
40. The Implications of Hospital Acquired Adverse Events on Mortality, Length of Stay and Costs for Patients Undergoing Radical Cystectomy for Bladder Cancer
41. Cost effectiveness of adjuvant pembrolizumab after nephrectomy for RCC: Insights for patient selection from a Markov model.
42. Authors' Reply
43. Contemporary Trends in Nephrectomy for Renal Cell Carcinoma in the United States: Results From a Population Based Cohort
44. Utilization and Cost Effectiveness of First-Line Yttrium-90 Ibritumomab Tiuxetan in Low-Grade Follicular and Marginal Zone Lymphomas Compared to Standard of Care Bendamustine Plus Rituximab: A Real-World Experience
45. Disparities in Surgical Care Among Women With Endometrial Cancer
46. Utilization of Minimally Invasive Surgery in Endometrial Cancer Care: A Quality and Cost Disparity
47. Comparative cost‐effectiveness of neoadjuvant chemotherapy regimens for muscle‐invasive bladder cancer: Results according to VESPER data.
48. Moral Traditionalism and the Kinds of School-Based Health Center Services Offered in the United States
49. Lifetime Cost and Quality-Adjusted Life-Years Across Management Options for Small- and Medium-Sized Sporadic Vestibular Schwannoma
50. Determinants of Direct Medical Costs in Primary and Revision Total Knee Arthroplasty
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.